Literature DB >> 11234983

Liver abscess caused by Clostridium difficile.

T Sakurai1, K Hajiro, H Takakuwa, A Nishi, M Aihara, T Chiba.   

Abstract

We report the first case of an infected cyst and liver abscess caused by Clostridium difficile. It recurred 11 months later, despite therapy with vancomycin and percutaneous drainage. Administration of metronidazole following percutaneous drainage achieved a favorable outcome.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11234983     DOI： 10.1080/003655401750064112

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  18 in total

1.  Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.

Authors:  Jennifer Steele; Kevin Chen; Xingmin Sun; Yongrong Zhang; Haiying Wang; Saul Tzipori; Hanping Feng
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo.

Authors:  Scott M Baliban; Amanda Michael; Berje Shammassian; Shikata Mudakha; Amir S Khan; Simon Cocklin; Isaac Zentner; Brian P Latimer; Laurent Bouillaut; Meredith Hunter; Preston Marx; Niranjan Y Sardesai; Seth L Welles; Jeffrey M Jacobson; David B Weiner; Michele A Kutzler
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

3.  Mouse relapse model of Clostridium difficile infection.

Authors:  Xingmin Sun; Haiying Wang; Yongrong Zhang; Kevin Chen; Barbara Davis; Hanping Feng
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  Invading beyond bounds: extraintestinal Clostridium difficile infection leading to pancreatic and liver abscesses.

Authors:  Moni Roy; Kumud Dahal; Ashish Kumar Roy
Journal:  BMJ Case Rep       Date:  2017-08-28

Review 5.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

6.  Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication.

Authors:  Elaine E Hamm; Daniel E Voth; Jimmy D Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

Review 7.  Clostridium difficile infection in patients with liver disease: a review.

Authors:  A Trifan; O Stoica; C Stanciu; C Cojocariu; A-M Singeap; I Girleanu; E Miftode
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-06       Impact factor: 3.267

8.  Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.

Authors:  T Scott Devera; Gillian A Lang; Jordi M Lanis; Pragya Rampuria; Casey L Gilmore; Judith A James; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2015-10-26       Impact factor: 3.441

9.  Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A.

Authors:  Xiangyun He; Xingmin Sun; Jufang Wang; Xiaoning Wang; Quanshun Zhang; Saul Tzipori; Hanping Feng
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

10.  Piglet models of acute or chronic Clostridium difficile illness.

Authors:  Jennifer Steele; Hanping Feng; Nicola Parry; Saul Tzipori
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.